Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin)
- Conditions
- Chronic Tinnitus
- Interventions
- Device: lf-tRNS
- Registration Number
- NCT02615600
- Lead Sponsor
- University of Regensburg
- Brief Summary
Stimulation of the left and right auditory cortex with daily low-frequency transcranial random noise stimulation (tRNS) is used to modulate the neural pathways involved in chronic tinnitus.
- Detailed Description
Tinnitus is the phantom auditory perception of sound in the absence of an external or internal acoustic stimulus. It is a frequent problem which can interfere significantly with the ability to lead a normal life. Tinnitus has been shown to be generated in the brain, as a result of functional reorganization of auditory neural pathways and the central auditory system. These changes are represented by hyper-activity and hyper-synchronicity in the auditory pathway. Treatment remains difficult. Non-invasive brain stimulation methods has shown to be effective in the treatment of chronic tinnitus with moderate effect size. First data suggest the use of transcranial random noise stimulation (tRNS) over both auditory cortices as new and highly effective treatment. Low-frequency (lf; \<100Hz) tRNS might be highly effective in tackling hyper-synchronised cell assemblies. Daily lf-tRNS (2 weeks) will be examined with regard to feasibility, safety and clinical efficacy in patients suffering from chronic tinnitus in an one-arm pilot trial.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description lf-tRNS lf-tRNS Low-frequency tRNS (Neuroconn, Eldith DC-Stimulator Plus): \<100Hz, 2mA, 20min, 10s ramp time, left and right auditory cortex, 5x7cm electrode with the inferior middle part over T3/T4
- Primary Outcome Measures
Name Time Method number of treatment responders week 12 response: tinnitus questionnaire total score reduction of at least 5 points, contrast baseline versus end of treatment (week 12)
- Secondary Outcome Measures
Name Time Method change in tinnitus questionnaire week 2, week 4, week 12 change in tinnitus questionnaire
change in tinnitus numeric rating scales week 2, week 4, week 12 change in tinnitus numeric rating scales
change in tinnitus handicap inventory week 2, week 4, week 12 change in tinnitus handicap inventory
Trial Locations
- Locations (1)
University of Regensburg - Deptartment of Psychiatry
🇩🇪Regensburg, Germany